lysophosphatidic acid has been researched along with Hepatic Encephalopathy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, M; Chakrabarti, M; Dasgupta, H; Kulkarni, OP; Mahale, A; Roy, S; Sharma, V; Tripathi, S | 1 |
Hamano, F; Kihara, Y; Masago, K; Nakagawa, S; Niwa, M; Shimizu, T; Yanagida, K | 1 |
2 other study(ies) available for lysophosphatidic acid and Hepatic Encephalopathy
Article | Year |
---|---|
Inhibition of Autotaxin Ameliorates LPA-Mediated Neuroinflammation and Alleviates Neurological Dysfunction in Acute Hepatic Encephalopathy.
Topics: Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Brain Diseases; Hepatic Encephalopathy; Interleukin-1beta; Interleukin-6; Lysophospholipids; Mice; Neuroinflammatory Diseases; Thioacetamide; Tumor Necrosis Factor-alpha | 2022 |
Lysophosphatidic acid receptor, LPA
Topics: Animals; Azoxymethane; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Cells, Cultured; Endothelial Cells; Hepatic Encephalopathy; Liver Failure, Acute; Lysophospholipids; Male; Mice, Inbred C57BL; Models, Biological; Phosphoric Diester Hydrolases; Rats; Receptors, Lysophosphatidic Acid; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction | 2018 |